101 related articles for article (PubMed ID: 23149704)
1. Indolent cutaneous B-cell lymphoma: diagnosis and treatment 2012.
Santucci M; Grandi V; Maio V; Delfino C; Alterini R; Pimpinelli N
G Ital Dermatol Venereol; 2012 Dec; 147(6):581-8. PubMed ID: 23149704
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous B-cell lymphomas.
Kempf W; Denisjuk N; Kerl K; Cozzio A; Sander C
J Dtsch Dermatol Ges; 2012 Jan; 10(1):12-22; quiz 23. PubMed ID: 22212142
[TBL] [Abstract][Full Text] [Related]
3. Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup.
Petit B; Chaury MP; Le Clorennec C; Jaccard A; Gachard N; Moalic-Judge S; Labrousse F; Cogné M; Bordessoule D; Feuillard J
Haematologica; 2005 Feb; 90(2):200-6. PubMed ID: 15710572
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG;
J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713
[TBL] [Abstract][Full Text] [Related]
5. Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma.
Senff NJ; Kluin-Nelemans HC; Willemze R
Br J Haematol; 2008 Jul; 142(1):52-6. PubMed ID: 18422781
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.
Baldassano MF; Bailey EM; Ferry JA; Harris NL; Duncan LM
Am J Surg Pathol; 1999 Jan; 23(1):88-96. PubMed ID: 9888708
[TBL] [Abstract][Full Text] [Related]
7. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
[TBL] [Abstract][Full Text] [Related]
9. Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma.
Peñate Y; Hernández-Machín B; Pérez-Méndez LI; Santiago F; Rosales B; Servitje O; Estrach T; Fernández-Guarino M; Calzado L; Acebo E; Gallardo F; Salar A; Izu R; Ortiz-Romero PL; Pujol RM; Fernández-de-Misa R
Br J Dermatol; 2012 Jul; 167(1):174-9. PubMed ID: 22356294
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma.
Bergman R; Kurtin PJ; Gibson LE; Hull PR; Kimlinger TK; Schroeter AL
Arch Dermatol; 2001 Apr; 137(4):432-9. PubMed ID: 11295923
[TBL] [Abstract][Full Text] [Related]
11. [Prognosis of primary cutaneous lymphomas].
Grange F; Bagot M
Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
[TBL] [Abstract][Full Text] [Related]
12. [Epitheliotropic lymphomas: better identification for improved treatment].
Bagot M
Bull Acad Natl Med; 2010 Oct; 194(7):1365-72. PubMed ID: 22043631
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT.
Paulli M; Arcaini L; Lucioni M; Boveri E; Capello D; Passamonti F; Merli M; Rattotti S; Rossi D; Riboni R; Berti E; Magrini U; Bruno R; Gaidano G; Lazzarino M
Ann Oncol; 2010 Jun; 21(6):1189-1195. PubMed ID: 19858084
[TBL] [Abstract][Full Text] [Related]
14. Primary gastric follicular lymphoma with parafollicular monocytoid B-cells and lymphoepithelial lesions, mimicking extranodal marginal zone lymphoma of MALT.
Tzankov A; Hittmair A; Müller-Hermelink HK; Rüdiger T; Dirnhofer S
Virchows Arch; 2002 Dec; 441(6):614-7. PubMed ID: 12461620
[TBL] [Abstract][Full Text] [Related]
15. [Cutaneous B-cell lymphoma].
Cortés B; Prins C
Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous involvement with marginal zone lymphoma.
Gerami P; Wickless SC; Querfeld C; Rosen ST; Kuzel TM; Guitart J
J Am Acad Dermatol; 2010 Jul; 63(1):142-5. PubMed ID: 20462658
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
Weisenburger DD
Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
[TBL] [Abstract][Full Text] [Related]
18. Marginal zone lymphoma with a dual cutaneous and leukemic presentation and an aberrant myeloid-monocytic phenotype.
Keehn CA; Cualing H
J Cutan Pathol; 2006 Mar; 33(3):236-41. PubMed ID: 16466512
[TBL] [Abstract][Full Text] [Related]
19. [Cutaneous large B-cell leg-type lymphoma occurring on a leg burn].
Meziane M; Hesse S; Chetaille B; Bien-Aimée A; Grob JJ; Richard MA
Ann Dermatol Venereol; 2009 Nov; 136(11):791-4. PubMed ID: 19917431
[TBL] [Abstract][Full Text] [Related]
20. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
